Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-038657

CEO and CFO bought 1,500 shares at $14.63 ($21,945)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2024-09-26 Purchase +1,500 $14.63 $21,945 5,536,102 D
Open-market purchases · 1,500 sh · avg $14.63 · $21,945
Loading xslF345X05/ownership.xml…